XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Accumulated Other Comprehensive Gain (loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019   44,864,000    
Beginning balance at Dec. 31, 2019 $ 111,091 $ 489,749 $ 21 $ (378,679)
Increase (Decrease) in Shareholders' Equity        
Net (loss) income 2,864     2,864
Stock-based compensation expense 13,843 $ 13,843    
Stock option exercises (in shares)   790,000    
Stock option exercises 5,582 $ 5,582    
Shares issued under the Employee Stock Purchase Plan (in shares)   117,000    
Shares issued under the Employee Stock Purchase Plan 1,050 $ 1,050    
Issuance of stock for restricted stock unit vesting (shares)   47,000    
Restricted stock withheld for employee tax remittance (in shares)   (14,000)    
Restricted stock withheld for employee tax remittance (163) $ (163)    
Unrealized loss on investments (7)   (7)  
Ending balance (in shares) at Dec. 31, 2020   45,804,000    
Ending balance at Dec. 31, 2020 134,260 $ 510,061 14 (375,815)
Increase (Decrease) in Shareholders' Equity        
Net (loss) income (7,471)     (7,471)
Stock-based compensation expense 34,322 $ 34,322    
Stock option exercises (in shares)   968,000    
Stock option exercises 9,928 $ 9,928    
Shares issued under the Employee Stock Purchase Plan (in shares)   43,000    
Shares issued under the Employee Stock Purchase Plan 1,256 $ 1,256    
Issuance of stock for restricted stock unit vesting (shares)   96,000    
Restricted stock withheld for employee tax remittance (in shares)   (31,000)    
Restricted stock withheld for employee tax remittance (1,665) $ (1,665)    
Unrealized loss on investments $ (168)   (168)  
Ending balance (in shares) at Dec. 31, 2021 46,880,000 46,880,000    
Ending balance at Dec. 31, 2021 $ 170,462 $ 553,902 (154) (383,286)
Increase (Decrease) in Shareholders' Equity        
Net (loss) income (16,709)     (16,709)
Stock-based compensation expense $ 37,183 $ 37,183    
Stock option exercises (in shares) 234,707 234,000    
Stock option exercises $ 2,401 $ 2,401    
Shares issued under the Employee Stock Purchase Plan (in shares)   49,000    
Shares issued under the Employee Stock Purchase Plan 1,251 $ 1,251    
Issuance of stock for restricted stock unit vesting (shares)   134,000    
Restricted stock withheld for employee tax remittance (in shares)   (44,000)    
Restricted stock withheld for employee tax remittance (1,492) $ (1,492)    
Unrealized loss on investments $ (824)   (824)  
Ending balance (in shares) at Dec. 31, 2022 47,253,000 47,253,000    
Ending balance at Dec. 31, 2022 $ 192,272 $ 593,245 $ (978) $ (399,995)